Celldex Therapeutics | CLDX - Passifs Courants





Passifs Courants Changement Date
AbbVie USD 43.29B 3.9B 2025-12
Agenus USD 323.49M 36.36M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celldex Therapeutics USD 50.99M 4.53M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Northwest Biotherapeutics USD 87.9M 3.98M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12